MedPath

Erythrocin Stearate

ERYTHROCIN STEARATE ERYTHROMYCIN STEARATE TABLETS, USP

Approved
Approval ID

6c789378-0ec7-4874-aa42-e3418e859f86

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 4, 2018

Manufacturers
FDA

Arbor Pharmaceuticals, Inc.

DUNS: 781796417

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ERYTHROMYCIN STEARATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code24338-106
Application NumberANDA060359
Product Classification
M
Marketing Category
C73584
G
Generic Name
ERYTHROMYCIN STEARATE
Product Specifications
Route of AdministrationORAL
Effective DateDecember 4, 2018
FDA Product Classification

INGREDIENTS (13)

powdered celluloseInactive
Code: SMD1X3XO9M
Classification: IACT
polacrilin potassiumInactive
Code: 0BZ5A00FQU
Classification: IACT
D&C Red No. 7Inactive
Code: ECW0LZ41X8
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
ERYTHROMYCIN STEARATEActive
Quantity: 250 mg in 1 1
Code: LXW024X05M
Classification: ACTIM
starch, cornInactive
Code: O8232NY3SJ
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMInactive
Code: K679OBS311
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
sorbic acidInactive
Code: X045WJ989B
Classification: IACT
sorbitan monooleateInactive
Code: 06XEA2VD56
Classification: IACT

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 12/4/2018

EST-PI-03 Revised: October 2018

Arbor Pharmaceuticals, LLC
Atlanta, GA 30328 USA

(No. 6346)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.